Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Y-33075

Y-33075 is a selective ROCK inhibitor derived from Y-27632, and is more potent than Y-27632, with an IC50 of 3.6 nM.

Product Specifications

CAS Number

199433-58-4

Product Name Alternative

Y-39983 (free base)

UNSPSC

12352005

Hazard Statement

H315, H319, H320

Target

ROCK

Type

Reference compound

Related Pathways

Cell Cycle/DNA Damage; Cytoskeleton; Stem Cell/Wnt; TGF-beta/Smad

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/Y-33075.html

Concentration

10mM

Purity

98.44

Solubility

DMSO : 50 mg/mL (ultrasonic; warming) |H2O : < 0.1 mg/mL

Smiles

O=C(NC1=C2C(NC=C2)=NC=C1)C3=CC=C(C=C3)[C@H](N)C

Molecular Formula

C16H16N4O

Molecular Weight

280.33

Precautions

H315, H319, H320

References & Citations

[1]Hideki Tokushige, et al. Effects of Topical Administration of Y-39983, a Selective Rho-Associated Protein Kinase Inhibitor, on Ocular Tissues in Rabbits and Monkeys Invest. Ophthalmol. Vis. Sci. July 2007 vol. 48no. 7 3216-3222|[2]Tokushige H, et al. Effects of Y-39983, a selective Rho-associated protein kinase inhibitor, on blood flow in optic nerve head in rabbits and axonal regeneration of retinal ganglion cells in rats. Curr Eye Res. 2011 Oct;36 (10) :964-70.|[3]Watabe H, et al. Effects of Rho-associated protein kinase inhibitors Y-27632 and Y-39983 on isolated rabbit ciliary arteries.Jpn J Ophthalmol. 2011 Jul;55 (4) :411-7. Epub 2011 Jun 11.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

Phase 2

Isoform

ROCK

Citation 01

Acta Neuropathol Commun. 2024 Sep 14;12 (1) :150.|bioRxiv. 2025 June 03.|Cell Death Dis. 2024 Dec 26;15 (12) :932.|Cells. 2024 Nov 18;13 (22) :1907.|J Cell Physiol. 2021 Dec;236 (12) :8226-8238.|Patent. US20170349879A1.|PLoS One. 2023 Jan 31;18 (1) :e0270288.|Stem Cell Rep. 2020 Jan 14;14 (1) :49-59.|Adv Sci (Weinh) . 2022 May;9 (13) :e2104682.|Cell. 2018 Jul 26;174 (3) :636-648.e18.|Harvard Medical School LINCS LIBRARY|J Adv Res. 2024 Sep:63:117-128.|Nat Commun. 2020 Jan 3;11 (1) :88.|Neurotox Res. 2013 Apr;23 (3) :238-48.|Science. 2017 Dec 1;358 (6367) :eaan4368.

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

UBC6e (UBE2J1) Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI3C11]
TA504969AM 100 µL

UBC6e (UBE2J1) Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI3C11]

Sign In for Pricing
View Details
CD52 Recombinant Rabbit Monoclonal Antibody [JE37-24]
HA722545 100 µL

CD52 Recombinant Rabbit Monoclonal Antibody [JE37-24]

Sign In for Pricing
View Details
Mogamulizumab Biosimilar - Research Grade
ICH5186-20mg 20 mg

Mogamulizumab Biosimilar - Research Grade

Sign In for Pricing
View Details
IL2 Receptor beta (IL2RB) Mouse Monoclonal Antibody [Clone ID: OTI1D1]
CF812259 100 µg

IL2 Receptor beta (IL2RB) Mouse Monoclonal Antibody [Clone ID: OTI1D1]

Sign In for Pricing
View Details
DDI2 Human Gene Knockout Kit (CRISPR)
KN218468BN 1 Kit

DDI2 Human Gene Knockout Kit (CRISPR)

Sign In for Pricing
View Details
Complement C4A (C4A) (NM_007293) Human Recombinant Protein
TP701080 50 µg

Complement C4A (C4A) (NM_007293) Human Recombinant Protein

Sign In for Pricing
View Details